Given the increasing demand for performance measures, the Academy is working proactively to ensure that dermatology has a say in the formulation of measures by which the performance of dermatologists is assessed. The Academy has a Performance Measurement Task Force (PMTF), chaired by Oliver Wisco, DO, FAAD, that identifies where value and quality in dermatology can be demonstrated. The task force and its work groups ensure that the interests of dermatologists and their patients are protected and that the Academy’s performance measures align with the Academy’s strategic framework and vision.Collecting measures in dermatology practice not only demonstrates value and quality, but also protects long-term interests while advancing dermatology.
The PMTF’s Psoriasis Work Group, led by Junko Takeshita, MD, PhD, FAAD, has developed quality measures for psoriasis for possible inclusion in the Physician Quality Reporting System (PQRS). Recently, the AAD talked with Dr. Takeshita about the measures and the process of developing them.
AAD: What was the task of the Psoriasis Work Group?
Dr. Takeshita: Our task was to create quality measures pertaining to psoriasis to submit for potential inclusion in the PQRS.
AAD: How was the work group constituted?
Dr. Takeshita: AAD work groups are appointed by the chair of a task force and generally consist of members who have expertise in one or more areas related to the main task of the work group.
AAD: What measures are included in the draft set?
Dr. Takeshita: Our draft set includes five measures, four of which are process-based and one of which is outcomes-based.
AAD: What do they seek to achieve?
Dr. Takeshita: Overall, they seek to ensure that psoriasis patients are getting appropriate medical care. For example, they seek to achieve this by making sure that patients are being educated about and screened for relevant co-morbid diseases and are reaching reasonable treatment goals.
AAD: What is the status of the psoriasis measure set?
Dr. Takeshita: The psoriasis measure set has been approved by the AAD’s Performance Measurement Task Force and will be forwarded to AAD leadership for approval. After AAD approval, current plans are to test the measure set and submit it to the National Quality Forum (NQF) for endorsement and to CMS to be considered for inclusion in PQRS
AAD: How will they demonstrate quality fo rdermatologists?
Dr. Takeshita: These measures address important aspects of care that dermatologists should be providing to their psoriasis patients. The measures will not only be important for demonstrating whether or not dermatologists are meeting the quality benchmarks but will also aid in providing much needed data to support evidence-based outcome measures.
Junko Takeshita, MD, PhD, is a post-doctoral research fellow and instructor in the Department of Dermatology at the University of Pennsylvania. She is a fellow of the American Academy of Dermatology, member of the AAD Performance Measurement Task force, and member of the Society for Investigative Dermatology. She is currently enrolled in the Master of Science in Clinical Epidemiology program at the University of Pennsylvania with research interests in epidemiology, clinical trials, and translational research related to psoriasis. Dr. Takeshita received her undergraduate training at Wellesley College. Her medical and doctoral degrees were obtained from Washington University in St. Louis. She completed an internship in internal medicine and dermatology residency at the University of Washington.
Related AAD resources: